Page values for "Crizotinib"
Jump to navigation
Jump to search
"_pageData" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| _pageID | Integer | 855,634 |
| _pageName | Page | Crizotinib |
| _pageTitle | String | Crizotinib |
| _pageNamespace | Integer | 0 |
"definitions" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| Term | Page | Crizotinib |
| Short_definition | String | Crizotinib - (pronounced) (krih-ZOH-tih feather) drug used to treat certain types of ALK-positive inflammatory myofibroblastic tumors in adults and children 1 year and older, ALK-positive systemic anaplastic large cell lymphoma in young adults and children 1 year and older, and ALK-positive or ROS1- |
| Type | Page | Cancer terms |
| Specialty | Page | Oncology |
| Language | Page | English |
| Source | Page | NCI |
| Comments | String |